Maxim Group analyst Naz Rahman reiterated a Buy rating on Palisade Bio (PALI – Research Report) yesterday. The company’s shares opened today at $0.70. Easily identify stocks' risks and ...

Maxim analyst Naz Rahman lowered the firm’s price target on scPharmaceuticals (SCPH) to $12 from $20 but keeps a Buy rating on the shares after its Q4 results. The firm expects the benefits from ...

Maxim Group analyst Naz Rahman reiterated a Buy rating on NexGel Inc yesterday and set a price target of $6.00. The company’s shares closed last Tuesday at $3.03. According to TipRanks.com ...

Detailed price information for Palisade Bio Inc (PALI-Q) from The Globe and Mail including charting and trades.